Filings in key mifepristone cases are being closely watched for signals that the Trump Justice Department will take a different approach than the Biden Administration. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
